OmniAb Investor Presentation Deck

The OmniAb Technology Offering TECHNOLOGY OFFERING ADDRESSES THE MOST CRITICAL CHALLENGES OF ANTIBODY DISCOVERY Technologies Create Create Diverse Repertoires of High-Quality Antibodies OmniRat OmniChicken OmniMouse Robust Antibodies for Any Target Omniflic Omni Clic Bispecific Antibody Computational Antigen Design & Proprietary Reagents Generation OmniTaur Cow-inspired Antibodies for Difficult Targets Screen Screen Millions of Cells to Find Potential Therapeutic Candidates xploration High-Throughput Single Cell Screening Gel Encapsulated Microenvironment (GEM) Single Cell Screening Ⓡ ● ● 0000 0000 Deliver Further Characterize, Select and Optimize the Right Antibody Custom Bioinformatics Next Generation Sequencing (NGS) Hit Expansion ● ICAGEN ION CHANNEL TECHNOLOGY ● ● Comprehensive Functional Characterization Proprietary lon Channel Assays STR: FC-Silencing Technology* STR of silico for and that are woven our various and Includes structural OmniDeep Sting, large multi-species antibody databases, molecular dynamics simulations, Al, and machine and deep learning sequence models, and more *OmniAb entered into an agreement with mAbsolve Ltd. for STR, mAbsolve's Fc-silencing platform technology, which provides OmniAb with exclusive, sublicensable right to incorporate the STR technology with antibodies that have been generated using OmniAb's antibody discovery platform. 12

View entire presentation